InvestorsHub Logo

steelyeye

10/30/20 10:42 AM

#330441 RE: farrell90 #330437

FDA trials, funding, partners are next milestones.



Cannot conceive it otherwise.

As soon as the money shows up, the share price will take off.

And with this Pre-Print I cannot imagine the money is very far off.

Wallstreet= "show me the money"

HolesInMyPockitz

10/30/20 10:58 AM

#330455 RE: farrell90 #330437

Thanks Farrell! Feeling so fortunate to have found this company and posters such as yourself.

Golfguru03

10/30/20 11:19 AM

#330468 RE: farrell90 #330437

Awesome news today and Brilacidin's potential and range of application is nothing short of amazing..

The area and usage I keep thinking about is as a preventative or prophylactic..developed as an inhaler or similar.

From your post: An inhaled form of Brilacidin will be studied soon as a preventative treatment for high risk individuals at the initiation of symptoms.

My question (thoughts) is that once symptoms are present, which might mean the virus is also present, it no longer is a prophylactic?...unless safety issues might prevent this, could a potential inhaler be used prior to symptoms, especially with "at risk" individuals..maybe even 2-3 times a week?

I realize that Brilacidin is not being developed as a "vaccine" but, again, I keep going back to it being a "preventative"...and "ease of application"..

Thanks Farrell for all you do here and for your expertise and scientific level-headed approach.

Mark

petemantx

10/30/20 11:19 AM

#330469 RE: farrell90 #330437

First time I have said this - Sticky Worthy!!

StockJumper25

10/30/20 1:07 PM

#330503 RE: farrell90 #330437

Farrell - At what level do you think, ad inhaled or injected version of Brilacidin would be effective for all of the following viruses?

I believe ( IMO) that an inhaled version would have the most efficacy against the top three Virus listed below, but not sure about the later.

1. Influenza viruses (both A and B) - including (H1N1)
2. Cold viruses like Rhinoviruses
3. MERS / SARS viruses probably better efficacy by inhaler
4. Noroviruses - by inject able Brilacidin
5. Hepatitis Viruses - by injection of B

6. What about HPV type viruses ?

If the Brilacidin drug can become a dominate solution either in part or combined with other drug combination therapies with the virus groups above, then there should be not reason for such a low PPS any longer for this new and soon to be approved medical technology. IMO of course.

Excited to see how this drug comes to fruition. The fruit is getting ripe.

Glad to be here.
GLTA

futrcash

10/30/20 4:00 PM

#330566 RE: farrell90 #330437

Appreciate your analysis-

futr